AdaptHealth (NASDAQ:AHCO) Rating Increased to Strong-Buy at Wall Street Zen

Wall Street Zen upgraded shares of AdaptHealth (NASDAQ:AHCO) from a buy rating to a strong-buy rating in a research report report published on Friday.

Other analysts have also issued reports about the company. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of AdaptHealth in a report on Saturday, September 27th. Zacks Research lowered AdaptHealth from a “hold” rating to a “strong sell” rating in a research report on Friday, September 19th. Five equities research analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $13.40.

AdaptHealth Price Performance

Shares of AHCO opened at $9.09 on Friday. The business’s 50-day moving average is $9.25 and its two-hundred day moving average is $9.11. The company has a market capitalization of $1.23 billion, a P/E ratio of 16.83, a P/E/G ratio of 1.01 and a beta of 1.61. AdaptHealth has a fifty-two week low of $7.11 and a fifty-two week high of $11.63. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06.

Insiders Place Their Bets

In other news, Director David Solomon Williams III sold 8,200 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director owned 50,045 shares in the company, valued at $486,937.85. This trade represents a 14.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.55% of the stock is owned by insiders.

Institutional Investors Weigh In On AdaptHealth

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AHCO. GAMMA Investing LLC lifted its stake in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company’s stock valued at $81,000 after purchasing an additional 4,758 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its holdings in shares of AdaptHealth by 6.8% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company’s stock worth $356,000 after acquiring an additional 2,081 shares during the last quarter. New York State Teachers Retirement System lifted its holdings in shares of AdaptHealth by 3.3% in the 1st quarter. New York State Teachers Retirement System now owns 80,455 shares of the company’s stock worth $872,000 after acquiring an additional 2,600 shares during the last quarter. Janney Montgomery Scott LLC purchased a new position in shares of AdaptHealth during the 1st quarter worth approximately $854,000. Finally, New York State Common Retirement Fund grew its stake in shares of AdaptHealth by 10.3% in the first quarter. New York State Common Retirement Fund now owns 836,773 shares of the company’s stock valued at $9,071,000 after buying an additional 78,211 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.